These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29451)

  • 101. Pharmacology and biochemistry of haloperidol.
    Niemegeers CJ; Laduron PM
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
    [No Abstract]   [Full Text] [Related]  

  • 102. The dopamine D1 receptor: biochemical and behavioral aspects.
    Andersen PH; Nielsen EB
    Adv Exp Med Biol; 1986; 204():73-91. PubMed ID: 2878580
    [No Abstract]   [Full Text] [Related]  

  • 103. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
    [No Abstract]   [Full Text] [Related]  

  • 104. Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs.
    Miller R; Wickens JR; Beninger RJ
    Prog Neurobiol; 1990; 34(2):143-83. PubMed ID: 1969668
    [No Abstract]   [Full Text] [Related]  

  • 105. A comparison of the vascular dopamine receptor with other dopamine receptors.
    Goldberg LI; Volkman PH; Kohli JD
    Annu Rev Pharmacol Toxicol; 1978; 18():57-79. PubMed ID: 348069
    [No Abstract]   [Full Text] [Related]  

  • 106. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
    Baldessarini RJ; Tarsy D
    Annu Rev Neurosci; 1980; 3():23-41. PubMed ID: 6106450
    [No Abstract]   [Full Text] [Related]  

  • 107. The hypotheses of different dopamine receptor mechanisms.
    Costall B; Naylor RJ
    Life Sci; 1981 Jan; 28(3):215-29. PubMed ID: 6111725
    [No Abstract]   [Full Text] [Related]  

  • 108. New concepts in dopamine receptor plasticity.
    LaHoste GJ; Marshall JF
    Ann N Y Acad Sci; 1993 Nov; 702():183-96. PubMed ID: 7906498
    [No Abstract]   [Full Text] [Related]  

  • 109. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Neuroscience; 1978; 3(9):773-83. PubMed ID: 30919
    [No Abstract]   [Full Text] [Related]  

  • 110. In vivo and in vitro intracellular recordings from rat midbrain dopamine neurons.
    Grace AA
    Ann N Y Acad Sci; 1988; 537():51-76. PubMed ID: 2849358
    [No Abstract]   [Full Text] [Related]  

  • 111. Normal and abnormal determinants of dopamine receptor ontogeny in the central nervous system.
    Feigenbaum JJ; Yanai J
    Prog Neurobiol; 1984; 23(3):191-225. PubMed ID: 6240665
    [No Abstract]   [Full Text] [Related]  

  • 112. The role of dopamine in rewarded behavior: ability, insight, drive or incentive?
    Willner P; Muscat R; Phillips G
    Pol J Pharmacol Pharm; 1991; 43(4):291-300. PubMed ID: 1811221
    [No Abstract]   [Full Text] [Related]  

  • 113. From molecules to behavior: new clues for RGS function in the striatum.
    Burns ME; Wensel TG
    Neuron; 2003 Jun; 38(6):853-6. PubMed ID: 12818171
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Anti-schizophrenic drugs--membrane receptor sites of action.
    Seeman P
    Biochem Pharmacol; 1977 Oct; 26(19):1741-8. PubMed ID: 20896
    [No Abstract]   [Full Text] [Related]  

  • 115. [Dopamine system].
    Sanada H; Hashimoto S; Midorikawa S; Watanabe T
    Nihon Rinsho; 2000 Jan; 58 Suppl 1():117-20. PubMed ID: 11026248
    [No Abstract]   [Full Text] [Related]  

  • 116. A clinical perspective on microdialysis.
    Pickar D
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S59-62. PubMed ID: 1982972
    [No Abstract]   [Full Text] [Related]  

  • 117. The rational use of drugs as therapeutic agents for the treatment of the alcoholisms.
    Wilcox RE; McMillen BA
    Alcohol; 1998 Feb; 15(2):161-77. PubMed ID: 9476962
    [No Abstract]   [Full Text] [Related]  

  • 118. Dopamine receptor mechanisms: behavioral and electrophysiological studies.
    Ungerstedt U; Ljungberg T; Schultz W
    Adv Biochem Psychopharmacol; 1978; 19():311-21. PubMed ID: 29451
    [No Abstract]   [Full Text] [Related]  

  • 119. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [TBL] [Abstract][Full Text] [Related]  

  • 120. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
    Arushanian EB
    Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.